Cargando…
Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina
Following previous metronomic meetings in Marseille (2011), Milano (2014), and Mumbai (2016), the first Latin American metronomic meeting was held in the School of Medical Sciences, National University of Rosario, Rosario, Argentina on 27 and 28 of May, 2016. For the first time, clinicians and resea...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cancer Intelligence
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014555/ https://www.ncbi.nlm.nih.gov/pubmed/27610198 http://dx.doi.org/10.3332/ecancer.2016.672 |
_version_ | 1782452311164977152 |
---|---|
author | Rosé, Adriana André, Nicolas Rozados, Viviana R. Mainetti, Leandro E Márquez, Mauricio Menacho Rico, María José Schaiquevich, Paula Villarroel, Milena Gregianin, Lauro Graupera, Jaume Mora García, Wendy Gómez Epelman, Sidnei Alasino, Carlos Alonso, Daniel Chantada, Guillermo Scharovsky, O Graciela |
author_facet | Rosé, Adriana André, Nicolas Rozados, Viviana R. Mainetti, Leandro E Márquez, Mauricio Menacho Rico, María José Schaiquevich, Paula Villarroel, Milena Gregianin, Lauro Graupera, Jaume Mora García, Wendy Gómez Epelman, Sidnei Alasino, Carlos Alonso, Daniel Chantada, Guillermo Scharovsky, O Graciela |
author_sort | Rosé, Adriana |
collection | PubMed |
description | Following previous metronomic meetings in Marseille (2011), Milano (2014), and Mumbai (2016), the first Latin American metronomic meeting was held in the School of Medical Sciences, National University of Rosario, Rosario, Argentina on 27 and 28 of May, 2016. For the first time, clinicians and researchers with experience in the field of metronomics, coming from different countries in Latin America, had the opportunity of presenting and discussing their work. The talks were organised in three main sessions related to experience in the pre-clinical, and clinical (paediatric and adult) areas. The different presentations demonstrated that the fields of metronomic chemotherapy and repurposing drugs in oncology, known as metronomics, constitute a branch of cancer therapy in permanent evolution, which have strong groups working in Latin America, both in the preclinical and the clinical settings including large, adequately designed randomised studies. It was shown that metronomics offers treatments, which, whether they are combined or not with the standard therapeutic approaches, are not only effective but also minimally toxic, with the consequent improvement of the patient’s quality of life, and inexpensive, a feature very important in low resource clinical settings. The potential use of metronomic chemotherapy was proposed as a cost/effective treatment in low-/middle-income countries, for adjuvant therapy in selected tumours. The fundamental role of the governmental agencies and non-governmental alliances, as the Metronomic Global Health Initiative, in supporting this research with public interest was underlined. |
format | Online Article Text |
id | pubmed-5014555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Cancer Intelligence |
record_format | MEDLINE/PubMed |
spelling | pubmed-50145552016-09-08 Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina Rosé, Adriana André, Nicolas Rozados, Viviana R. Mainetti, Leandro E Márquez, Mauricio Menacho Rico, María José Schaiquevich, Paula Villarroel, Milena Gregianin, Lauro Graupera, Jaume Mora García, Wendy Gómez Epelman, Sidnei Alasino, Carlos Alonso, Daniel Chantada, Guillermo Scharovsky, O Graciela Ecancermedicalscience Conference Report Following previous metronomic meetings in Marseille (2011), Milano (2014), and Mumbai (2016), the first Latin American metronomic meeting was held in the School of Medical Sciences, National University of Rosario, Rosario, Argentina on 27 and 28 of May, 2016. For the first time, clinicians and researchers with experience in the field of metronomics, coming from different countries in Latin America, had the opportunity of presenting and discussing their work. The talks were organised in three main sessions related to experience in the pre-clinical, and clinical (paediatric and adult) areas. The different presentations demonstrated that the fields of metronomic chemotherapy and repurposing drugs in oncology, known as metronomics, constitute a branch of cancer therapy in permanent evolution, which have strong groups working in Latin America, both in the preclinical and the clinical settings including large, adequately designed randomised studies. It was shown that metronomics offers treatments, which, whether they are combined or not with the standard therapeutic approaches, are not only effective but also minimally toxic, with the consequent improvement of the patient’s quality of life, and inexpensive, a feature very important in low resource clinical settings. The potential use of metronomic chemotherapy was proposed as a cost/effective treatment in low-/middle-income countries, for adjuvant therapy in selected tumours. The fundamental role of the governmental agencies and non-governmental alliances, as the Metronomic Global Health Initiative, in supporting this research with public interest was underlined. Cancer Intelligence 2016-09-06 /pmc/articles/PMC5014555/ /pubmed/27610198 http://dx.doi.org/10.3332/ecancer.2016.672 Text en © the authors; licensee ecancermedicalscience. http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Conference Report Rosé, Adriana André, Nicolas Rozados, Viviana R. Mainetti, Leandro E Márquez, Mauricio Menacho Rico, María José Schaiquevich, Paula Villarroel, Milena Gregianin, Lauro Graupera, Jaume Mora García, Wendy Gómez Epelman, Sidnei Alasino, Carlos Alonso, Daniel Chantada, Guillermo Scharovsky, O Graciela Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina |
title | Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina |
title_full | Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina |
title_fullStr | Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina |
title_full_unstemmed | Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina |
title_short | Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 May, 2016, Rosario, Argentina |
title_sort | highlights from the 1st latin american meeting on metronomic chemotherapy and drug repositioning in oncology, 27–28 may, 2016, rosario, argentina |
topic | Conference Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5014555/ https://www.ncbi.nlm.nih.gov/pubmed/27610198 http://dx.doi.org/10.3332/ecancer.2016.672 |
work_keys_str_mv | AT roseadriana highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT andrenicolas highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT rozadosvivianar highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT mainettileandroe highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT marquezmauriciomenacho highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT ricomariajose highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT schaiquevichpaula highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT villarroelmilena highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT gregianinlauro highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT grauperajaumemora highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT garciawendygomez highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT epelmansidnei highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT alasinocarlos highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT alonsodaniel highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT chantadaguillermo highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina AT scharovskyograciela highlightsfromthe1stlatinamericanmeetingonmetronomicchemotherapyanddrugrepositioninginoncology2728may2016rosarioargentina |